Labs / Assays & in vitro testing
RG Discovery
Lund, Sweden · rgdiscovery.com
RG Discovery is a Scandinavian CRO based in Lund, Sweden. It provides integrated drug discovery, analysis, and custom synthesis services for small molecules, peptides, and macrocycles for biotech, pharmaceutical, and academic clients.
They take quote requests by email.
What they offer
Medicinal Chemistry
Provides medicinal and synthetic chemistry support to drive projects from targets to lead compounds and clinical candidates.
In Vitro Biology – Assays & Screening
Develops and runs biochemical and cell-based screening assays and biomarker analysis for drug discovery projects.
ADME & Bioanalysis
Provides bioanalytical and physicochemical services such as solubility, lipophilicity, plasma stability, microsome metabolism, and plasma protein binding.
Fragment Screening
Operates an integrated fragment-based lead discovery platform for hit finding and validation.
Computational Chemistry
Uses in silico methods to provide molecular-level insights for drug discovery and development.
Peptide Chemistry
Provides custom peptide synthesis and drug discovery services for industry and academia.
Analytical Chemistry
Offers customized analytical chemistry services for drug discovery and custom synthesis projects.
Custom Synthesis
Provides tailored chemical synthesis services to support client projects.
NMR Spectroscopy
Provides NMR analysis for structural and conformational characterization.
Chemical Analysis & Separation
Supports compound analysis and separation needs within drug discovery workflows.
Compound Management
Manages compounds within its drug discovery platform to support project workflows.
What they work on
- Modalities
- Small molecule, Peptide
- Assays and studies
- biochemical screening assays, cell-based screening assays, biomarker analysis, fragment screening, ligand-detected 1D 1H/19F NMR, differential scanning fluorimetry, high concentration screening, HPLC-MS/MS analysis, solubility screening, plasma stability, microsome in vitro metabolism, plasma protein binding
- Instruments and platforms
- HPLC-MS/MS, WAC™, NMR, fluorescence polarization, microplate reader platform
- Scale and capacity
- close to 3000 employees at Medicon Village park, one laboratory building
- Therapeutic areas
- oncological conditions, CNS disease indications, digestive system disease
- Turnaround
- weekly basis
- Type
- CRO
- Sites
- Lund, Sweden
- Serves
- global, Scandinavia
Public records
- Ownership
- RG Discovery AB · SE GLEIF
Similar labs. MedChem Partners, Biotest Facility, Devsynthesis, EyeCRO
Found in a contract services directory. Listing built from rgdiscovery.com. Work here? Claim this listing.